As of 2025-09-18, the Fair Value of BioXcel Therapeutics Inc (BTAI) is -17.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.90 USD, the upside of BioXcel Therapeutics Inc is -703.33%.
With the market price of 2.90 USD and our fair value calculation, BioXcel Therapeutics Inc (BTAI) is not a good investment. Investing in BioXcel stocks now will result in a potential loss of 703.33%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -82.17 | -106.93 | -165.76 | -179.05 | -59.60 | -118.70 |
| YoY growth | -149.23% | -30.13% | -55.02% | -8.02% | 66.71% | -35.14% |
| Market Cap (mil) | 42.22 |
| P/E | |
| Forward P/E |
| EPS | -3.50 |
| Avg earnings growth rate | -35.14% |
| TTM earnings | -50.95 |